Efficacy and Safety of RAD001 in Treating Plexiform Neurofibromas (PN) Associated With Neurofibromatosis (NF1)
Stopped Poor patients' accrual
Conditions
- Plexiform Neurofibroma Associated With Neurofibromatosis Type 1
Interventions
- DRUG: Everolimus (RAD001)
Sponsor
Novartis Pharmaceuticals